Natalizumab treatment shows no clinically meaningful effects on immunization responses in patients with relapsing-remitting multiple sclerosis

Document Details

Document Type
Pub Defense Publication
Publication Date
Jun 01, 2014
Source ID
10.1016/j.jns.2014.03.035

Entities

People

  • Fiona Forrestal
  • Gabriel Pardo
  • Howard Rossman
  • Marianne T. Sweetser
  • Michael Kaufman
  • Petra Duda

Organizations

  • Biogen